Rishad Khan
Overview
Explore the profile of Rishad Khan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
575
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khan R, Marchena-Romero K, Ismail M, Roberts S, Gimpaya N, Scaffidi M, et al.
Endosc Int Open
. 2025 Feb;
13:a24947333.
PMID: 39958657
Background And Study Aims: Endoscopic retrograde cholangiopancreatography (ERCP) is important in acute cholangitis (AC) management but is not available at all hospitals. The association between on-site ERCP availability and cholangitis...
2.
3.
Ceccacci A, Hothi H, Khan R, Gimpaya N, Chan B, Forbes N, et al.
Endosc Int Open
. 2024 Dec;
12(12):E1465-E1475.
PMID: 39691740
Competent endoscopic ultrasound (EUS) performance requires a combination of technical, cognitive, and non-technical skills. Direct observation assessment tools can be employed to enhance learning and ascertain clinical competence; however, there...
4.
Sabrie N, Gimpaya N, Khalaf K, Deeb M, Mhalawi W, Meleka M, et al.
J Can Assoc Gastroenterol
. 2024 Dec;
7(6):411-415.
PMID: 39679098
Background: ERCP is a technically demanding procedure that carries a high cumulative adverse event (AE) rate of >10%. Identifying risk factors for adverse events is paramount. Procedure timing, as a...
5.
James P, Almousawi F, Salim M, Khan R, Tanuseputro P, Hsu A, et al.
Clin Transl Gastroenterol
. 2024 Dec;
16(1):e00774.
PMID: 39620578
Introduction: Patients with pancreatic ductal adenocarcinoma (PDAC) face challenging treatment decisions following their diagnosis. We developed and validated a survival prognostication model using routinely available clinical information, patient-reported symptoms, performance...
6.
Bishay K, Meng Z, Khan R, Gupta M, Ruan Y, Vaska M, et al.
Gastroenterology
. 2024 Nov;
168(3):568-586.
PMID: 39515394
Background & Aims: Endoscopic retrograde cholangiopancreatography (ERCP)-related adverse events (AEs) are associated with morbidity, mortality, and health care expenditure. We aimed to assess incidences and comparisons of ERCP AEs. Methods:...
7.
Khan R, Law R
Gastroenterol Clin North Am
. 2024 Nov;
53(4):683-707.
PMID: 39489582
Therapeutic endoscopic ultrasound (EUS) encompasses an array of procedures to manage pancreaticobiliary and luminal gastrointestinal disorders. Therapeutic EUS procedures include EUS-guided rendezvous of the pancreatic and biliary ducts, as well...
8.
Khan R, Samnani S, Vaska M, Grover S, Walsh C, Mosko J, et al.
Endosc Int Open
. 2024 Oct;
12(2):2.
PMID: 39444524
[This corrects the article DOI: 10.1055/a-2221-7792.].
9.
Ceccacci A, Gupta M, Eisele M, Khan R, Besney J, Guo H, et al.
Endoscopy
. 2024 Sep;
57(3):220-227.
PMID: 39299267
Background: Post-endoscopic retrograde cholangiopancreatography (ERCP) adverse events (AEs) are common, as is unplanned healthcare utilization (UHU). We aimed to assess potential etiologic associations between intra-/post-procedural patient-reported experience measures (PREMs) and...
10.